Elevated proangiogenic markers are associated with vascular complications within Ghanaian sickle cell disease patients

dc.contributor.authorCharles Antwi-Boasiako
dc.contributor.authorEmmanuel Frimpong
dc.contributor.authorBen Gyan
dc.contributor.authorEric Kyei-Baafour
dc.contributor.authorFredericka Sey
dc.contributor.authorBartholomew Dzudzor
dc.contributor.authorMubarak Abdul-Rahman
dc.contributor.authorGifty B. Dankwah
dc.contributor.authorKate H. Otu
dc.contributor.authorTom A. Ndanu
dc.contributor.authorAndrew D. Campbell
dc.contributor.authorIvy Ekem
dc.contributor.authorEric S. Donkor
dc.date.accessioned2026-06-02T13:56:17Z
dc.date.issued2018-06-22
dc.description9p,; ill
dc.description.abstractSickle cell disease (SCD) is an inherited blood disorder that can result in vasculopathy and end organ damage. Angiogenesis has been implicated as a key contributing factor to vascular mediated tissue injury in SCD. The relative plasma levels of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and vascular endothelial growth factor (VEGF) greatly influence angiogenesis. Dysregulation of these growth factors, leading to a pro-angiogenic state in SCD patients, has been documented in the developed world but there is very little data in Africa. There is the need, therefore, for studies in Ghanaian SCD patients. The aim of this study was to assess plasma levels of Ang-1, Ang-2, and VEGF in homozygous (HbSS) SCD patients with or without complications and healthy controls (HbAA) in Ghana. The study was a case-control study involving 544 participants: 396 HbSS SCD patients and 148 HbAA healthy controls. The study was conducted at the Center for Clinical Genetics (Sickle Cell Clinic) and Accra Area Blood Centre for National Blood transfusion at the Korle-Bu Teaching Hospital, Accra, Ghana. The plasma levels of Ang-1, Ang-2, and VEGF of study participants were measured with a double sandwich enzyme-linked immunosorbent assay (ELISA) technique. Complete blood count (CBC) was measured with an autoanalyser. The mean plasma Ang-1, Ang-2, and VEGF were significantly higher in HbSS SCD patients with or without complications than healthy controls (p < 0.001). The Ang-2/Ang-1 ratio was significantly lower in the controls than the HbSS patients (p < 0.001). The Ang-2/Ang-1 ratio was higher in the HbSS patients with leg ulcers as compared with patients with other complications and healthy controls (p < 0.001). There were higher leucocyte counts in HbSS patients than healthy controls. Overall, there was elevated plasma levels of Ang-1, Ang-2, and VEGF in SCD patients. The higher Ang-2/Ang-1 plasma levels in patients with leg ulcers suggests a possible ongoing angiogenesis and response to inflammatory stimuli. The study provides a first report on plasma levels of angiopoietin-1, angiopoietin-2, and vascular endothelial growth factors in homozygous sickle cell disease patients in Ghana.
dc.identifier.issn23105496
dc.identifier.urihttps://uir.ucc.edu.gh/handle/123456789/1346
dc.language.isoen_US
dc.publisherUniversity of Cape Coast
dc.subjectsickle cell disease
dc.subjectangiogenic factors
dc.subjectangiopoietin-1
dc.subjectangiopoietin-2
dc.subjectvascular endothelial growth factor
dc.titleElevated proangiogenic markers are associated with vascular complications within Ghanaian sickle cell disease patients
dc.typeArticle

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Elevated Proangiogenic Markers are Associated with (2).pdf
Size:
246.17 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description: